marksman kateter
sonimed d.o.o., zagreb - mikrokateteri za opću intravaskularnu upotrebu
avastin 100 mg/4 ml koncentrat otopine za infuziju
roche d.o.o.roche ltd. - bevacizumab - koncentrat otopine za infuziju - 100 mg/4 ml - 4 ml koncentrata za otopinu za infuziju sadrži: 100 mg bevacizumab (25 mg/ml)
avastin 400 mg/16 ml koncentrat otopine za infuziju
roche d.o.o.roche ltd. - bevacizumab - koncentrat otopine za infuziju - 400 mg/16 ml - 16 ml kocentrata za otopinu za infuziju sadrži: 400 mg bevacizumab (25 mg/ml)
ciprozad 250 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 250 mg/1 tableta - 1 filmtableta sadrži: 250 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorid, monohidrata)
ciprozad 500 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 filmtableta sadrži: 500 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorid, monohidrata)
ciprozad 500 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 film tableta sadrži: 500 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorid, monohidrata)
ciprozad 500 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 filmtableta sadrži: 500 mg ciprofloksacina (u obliku ciprofloksacinhidrohlorid, monohidrata)
ciprozad 500 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 film tableta sadrži: 500 mg ciprofloksacina (u obliku ciprofloksacinhidrohlorid, monohidrata)
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicin hidroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
moxi 400 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - moksifloksacin - film tableta - 400 mg/1 tableta - 1 film tableta sadrži 400 mg moksifloksacina (u obliku moksifloksacinhidrohlorida)